Cabalit, Trista Danea S.

HRN: 21-41-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/05/2022
06/11/2022
IV
500mg
Q8h
S/P CS With IUD Insertion
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: